Molecularly targeted therapies for metastatic triple-negative breast cancer von Bayraktar, Soley, Glück, Stefan

Volltext

Frequency and Vehicle Capacity Determination using a Dynamic Transit Assignment Model von Cats, Oded, Glück, Stefan

Volltext

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy von Glück, Stefan, de Snoo, Femke, Peeters, Justine, Stork-Sloots, Lisette, Somlo, George

Volltext

Participation in Cancer Clinical Trials: Why Are Patients Not Participating? von Byrne, Margaret M., Tannenbaum, Stacey L., Glück, Stefan, Hurley, Judith, Antoni, Michael

Volltext

Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer von Glück, Stefan, MD, PhD, FRCPC

Volltext

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival comp... von Koru-Sengul, Tulay, Santander, Ana M., Miao, Feng, Sanchez, Lidia G., Jorda, Merce, Glück, Stefan, Ince, Tan A., Nadji, Mehrad, Chen, Zhibin, Penichet, Manuel L, Cleary, Margot P., Torroella-Kouri, Marta

Volltext

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab von Glück, Stefan, Ross, Jeffrey S., Royce, Melanie, McKenna, Edward F., Perou, Charles M., Avisar, Eli, Wu, Lin

Volltext

A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer von Montero, Alberto J., Avancha, Kiran, Glück, Stefan, Lopes, Gilberto

Volltext

Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor–positive metastatic breast cancer von Bayraktar, Soley, Batoo, Sameer, Al-Hattab, Eyad, Basu, Sandeep, Okuno, Scott, Glück, Stefan

Volltext

How Stress Management Improves Quality of Life After Treatment for Breast Cancer von Antoni, Michael H., Kazi, Aisha, Wimberly, Sarah R., Sifre, Tammy, Urcuyo, Kenya R., Phillips, Kristin, Lechner, Suzanne C., Glück, Stefan, Carver, Charles S.

Volltext

How Stress Management Improves Quality of Life After Treatment for Breast Cancer von Antoni, Michael H, Lechner, Suzanne C, Kazi, Aisha, Wimberly, Sarah R, Sifre, Tammy, Urcuyo, Kenya R, Phillips, Kristin, Glück, Stefan, Carver, Charles S

Volltext

Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up von Antoni, Michael H., PhD, Jacobs, Jamie M., PhD, Bouchard, Laura C., MS, Lechner, Suzanne C., PhD, Jutagir, Devika R., MS, Gudenkauf, Lisa M., PhD, Blomberg, Bonnie B., PhD, Glück, Stefan, MD, PhD, Carver, Charles S., PhD

Volltext

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC) von Nekljudova, Valentina, Loibl, Sibylle, von Minckwitz, Gunter, Schneeweiss, Andreas, Glück, Stefan, Crane, Richard, Li, Huiling, Luo, Xiaolong

Volltext

A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer von Lopes, Gilberto, Glück, Stefan, Avancha, Kiran, Montero, Alberto J.

Volltext

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative... von Yepes, Monica Maria, Romilly, Ada Pat, Collado-Mesa, Fernando, Net, Jose Miguel, Kiszonas, Richard, Arheart, Kristopher L., Young, Daniel, Glück, Stefan

Volltext

Introduction to special issue Translational goals of neoadjuvant therapy von Gluck, Stefan

Volltext

Randomized Controlled Trial of Cognitive Behavioral Stress Management in Breast Cancer: A Brief Report of Effects on 5-Year Depressive Symptoms von Stagl, Jamie M., Antoni, Michael H., Lechner, Suzanne C., Bouchard, Laura C., Blomberg, Bonnie B., Glück, Stefan, Derhagopian, Robert P., Carver, Charles S.

Volltext

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer von Lobo, Christopher, Lopes, Gilberto, Baez, Odalys, Castrellon, Aurelio, Ferrell, Annapoorna, Higgins, Connie, Hurley, Erin, Hurley, Judith, Reis, Isildinha, Richman, Stephen, Seo, Pearl, Silva, Orlando, Slingerland, Joyce, Tukia, Keleni, Welsh, Catherine, Glück, Stefan

Volltext

Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting von Dranitsaris, George, BPharm, PhD, Gluck, Stefan, MD, Faria, Claudio, Pharm D, MPH, Cox, David, PhD, Rugo, Hope, MD

Volltext

The Prevention and Management of Distant Metastases in Women with Breast Cancer von Glück, Stefan

Volltext